Ceftobiprole

Caitlin Soto, PharmD, BCIDP

INDICATIONS

FDA

  • Adult patients with Staphylococcus aureus bloodstream infections (bacteremia) (SAB), including those with right-sided infective endocarditis
  • Adult patients with acute bacterial skin and skin structure infections (ABSSSI)
  • Adult and pediatric patients (3 months to less than 18 years old) with community-acquired bacterial pneumonia (CABP)

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: May 11, 2025